Blood Science
Scope & Guideline
Unveiling Insights in Blood Health and Disorders
Introduction
Aims and Scopes
- Hematological Malignancies:
Research on various blood cancers, including acute myeloid leukemia, multiple myeloma, and lymphomas, focusing on their pathogenesis, genetic mutations, and novel treatment approaches. - Translational Medicine:
Studies bridging laboratory research and clinical practice, including the evaluation of new therapies, prognostic models, and treatment outcomes in hematological patients. - Immune Modulation and Therapy:
Exploration of immune mechanisms in hematology, including CAR-T cell therapy, immune checkpoint inhibitors, and the role of the immune microenvironment in blood disorders. - Stem Cell Biology:
Investigation of hematopoietic stem cells, their differentiation pathways, and the impact of the bone marrow niche on stem cell function and disorders. - Epigenetics and Molecular Mechanisms:
Research on the epigenetic modifications and molecular pathways involved in hematopoiesis and hematological diseases, shedding light on novel therapeutic targets. - Iron Metabolism and Hematopathologies:
Focus on iron regulation in the context of hematological disorders, examining its implications in diseases such as anemia and myelodysplastic syndromes. - Microbiome and Hematopoiesis:
Studies investigating the interactions between gut microbiota and hematopoietic processes, highlighting their influence on health and disease.
Trending and Emerging
- Targeted Therapies and Precision Medicine:
Increasing emphasis on the development and application of targeted therapies, including CAR-T cell therapy and small molecular inhibitors, to improve outcomes in hematological malignancies. - Single-Cell Analysis Techniques:
Emerging use of single-cell RNA sequencing and other advanced techniques to understand the heterogeneity of hematopoietic cells and their implications in disease progression. - Gut Microbiota and Hematological Health:
Growing interest in the role of gut microbiota in influencing hematopoiesis and the immune response, highlighting its potential as a therapeutic target. - Epigenetic and Molecular Pathways:
A surge in research focusing on epigenetic changes and molecular mechanisms that drive hematological conditions, providing insights into novel treatment strategies. - Immune Microenvironment Reprogramming:
Emerging studies targeting the tumor immune microenvironment, particularly macrophage reprogramming, to enhance immunotherapy efficacy in blood cancers. - Biomarkers for Prognosis and Treatment Response:
Increased focus on identifying biomarkers that can predict treatment response and disease prognosis, facilitating personalized treatment approaches in hematology.
Declining or Waning
- Traditional Chemotherapy Approaches:
There is a noticeable decrease in studies focused solely on conventional chemotherapy regimens, as the field shifts towards more targeted and personalized treatment strategies. - Historical Treatments for Hematological Disorders:
Research centered on older treatment modalities, such as older immunosuppressive therapies or less effective transfusion methods, is becoming less common as new therapies emerge. - Basic Hematology Studies:
Basic studies that do not link findings to clinical applications or translational research are appearing less frequently, indicating a trend towards research that can directly impact patient outcomes.
Similar Journals
Therapeutic Advances in Hematology
Transforming research into impactful therapies.Therapeutic Advances in Hematology is a prestigious, peer-reviewed journal dedicated to advancing the field of hematology through innovative research and clinical studies. Published by SAGE Publications Ltd, this journal has become a vital resource for hematology professionals and researchers since its inception in 2010. With its impactful Q1 ranking in Hematology and a Scopus rank of 62 out of 137, it firmly establishes itself as a leader in disseminating significant findings and therapeutic approaches. The journal has been committed to open access since 2019, ensuring that its cutting-edge research is readily available to the global scientific community. Covering a broad scope of topics within hematology, Therapeutic Advances in Hematology is an essential platform for those seeking to enhance their understanding and implementation of therapeutic practices in hematological conditions. The journal embraces submissions from both clinical and laboratory perspectives, fostering collaboration and dialogue among researchers, clinicians, and students alike.
LEUKEMIA RESEARCH
Catalyzing discoveries in the fight against leukemia.Leukemia Research is a prominent academic journal dedicated to advancing the field of hematology and oncology, focusing on the latest research developments related to leukemia and other hematological disorders. Founded in 1977 and published by Pergamon-Elsevier Science Ltd in the United Kingdom, this esteemed journal has established itself as a vital resource for researchers and clinicians alike. With an impressive impact factor and categorized in the top quartiles of Cancer Research and Hematology, it provides a platform for high-quality research articles, reviews, and clinical studies that contribute to a deeper understanding of leukemia's complexities. Although not an Open Access journal, Leukemia Research ensures widespread dissemination of knowledge crucial for developing innovative treatment strategies and improving patient outcomes. Researchers, professionals, and students in the fields of hematology and oncology will find this journal an invaluable asset in staying at the forefront of leukemia research, as it prepares to expand its impact through converged years of publication extending into 2024.
BLOOD CELLS MOLECULES AND DISEASES
Decoding Cellular Mechanisms Behind Blood DisordersBLOOD CELLS MOLECULES AND DISEASES is a prominent multidisciplinary journal published by Academic Press Inc., Elsevier Science, specializing in the fields of hematology, molecular biology, and cell biology. With an ISSN of 1079-9796 and an E-ISSN of 1096-0961, this journal serves as a vital resource for researchers, professionals, and students exploring the complex interplay between blood cells and their corresponding molecular pathways in disease states. Spanning topics from cellular mechanisms to therapeutic advancements, BLOOD CELLS MOLECULES AND DISEASES holds a commendable reputation with a 2023 category quartile ranking of Q2 in Hematology and Q3 in several related fields. This journal not only provides a platform for the dissemination of innovative research but also fosters collaboration and knowledge exchange within the scientific community. As it converges from 1995 to 2025, the journal continues to impact the medical and biological sciences significantly, making it an essential tool for advancing our understanding of hematologic diseases.
Journal of Hematology
Connecting Scholars, Enhancing PracticeThe Journal of Hematology, published by ELMER PRESS INC, serves as a pivotal platform for disseminating cutting-edge research in the field of hematology. With an ISSN of 1927-1212 and an E-ISSN of 1927-1220, this journal is committed to advancing scientific knowledge and clinical practice through high-quality peer-reviewed articles encompassing all aspects of blood disorders, from basic science to health policy implications. While the journal currently operates under a traditional access model, it nonetheless prioritizes the rapid publication of significant findings, ensuring that researchers, clinicians, and students have timely access to the latest advancements in hematological research. Positioned to bridge gaps in knowledge and foster collaboration among scholars worldwide, the Journal of Hematology is an essential resource for anyone invested in this vital area of medicine.
HemaSphere
Exploring the frontiers of hematology research.HemaSphere, published by WILEY, stands at the forefront of hematology research, offering a vital platform for the dissemination of cutting-edge findings in the field. Since its inception in 2017 and official transition to Open Access in 2018, the journal has positioned itself as a leading conduit for high-impact research, maintaining a prestigious Q1 quartile ranking in the Hematology category as of 2023. Addressed in the United States at 111 River St, Hoboken, NJ, HemaSphere aims to foster a global dialogue among researchers, clinicians, and students by providing unrestricted access to high-quality content that encompasses clinical and experimental advancements. With an array of engaging articles, reviews, and commentaries, HemaSphere contributes significantly to the advancement of hematology, ensuring that critical knowledge is readily accessible to enhance patient care and innovative research. To explore the latest developments and breakthroughs in this dynamic field, we invite scholars, professionals, and students to engage with HemaSphere and elevate their understanding of hematologic science.
INTERNATIONAL JOURNAL OF HEMATOLOGY
Advancing the Science of Blood HealthThe INTERNATIONAL JOURNAL OF HEMATOLOGY, published by SPRINGER JAPAN KK, serves as a critical platform for advancing research in the field of hematology. With a prestigious history spanning over three decades from 1991 to 2024, this journal is recognized for its impactful contributions, evidenced by its Q2 category ranking in Hematology for 2023, and its notable position at rank #71 out of 137 in the Scopus Medicine Hematology category. Researchers and professionals within the hematology community benefit from the journal's rigorous peer-reviewed articles that cover a wide range of topics, including clinical studies, basic research, and novel therapeutic strategies. Though currently non-open access, it provides essential insights and findings to an audience passionate about the latest advancements in blood disorders and treatments. Situated in Japan, the journal not only showcases high-quality research but also fosters a global exchange of knowledge in hematology, making it a significant resource for scholars, practitioners, and students alike.
CANCER GENE THERAPY
Unleashing the Power of Molecular Medicine in OncologyCancer Gene Therapy, published by SpringerNature, stands at the forefront of research in the fields of cancer research, molecular biology, and molecular medicine. With a robust impact factor reflecting its significant influence—ranking in the Q2 category for cancer research and Q1 for both molecular biology and molecular medicine—it serves as an essential resource for scholars and practitioners alike. Since its inception in 1994, the journal has dedicated itself to advancing the understanding and therapeutic application of genetic innovations in oncology. Notably, it holds distinguished Scopus ranks, placing it among the top tier journals in its categories, underscoring its importance to the scientific community. While open access options are not available, the compelling research published here offers invaluable insights into the latest advancements and strategies in cancer therapy. Engaging with *Cancer Gene Therapy* not only keeps professionals informed but also inspires future innovations in the quest for effective cancer treatments.
STEM CELLS AND DEVELOPMENT
Empowering the Future of Regenerative MedicineSTEM CELLS AND DEVELOPMENT, published by Mary Ann Liebert, Inc., is a leading peer-reviewed journal dedicated to the rapidly advancing fields of stem cell biology and developmental science. With an ISSN of 1547-3287 and an E-ISSN of 1557-8534, the journal encompasses a broad range of topics central to understanding stem cells' roles in development and regeneration processes. It holds a prestigious standing within its category quartiles, ranking Q3 in Cell Biology, Q2 in Developmental Biology, and Q2 in Hematology for 2023. With its convergence from 2004 to 2024, STEM CELLS AND DEVELOPMENT fosters an innovative platform for researchers, professionals, and students to disseminate groundbreaking research, share insights, and explore novel therapeutic approaches. Open access options enhance the journal's visibility and accessibility, promoting a collaborative exchange of information among the scientific community. Positioned at the forefront of stem cell research and its applications, this journal is vital for anyone seeking to stay informed about the latest advancements and trends within these critical areas of study.
Egyptian Journal of Haematology
Fostering Collaboration for a Healthier Tomorrow in HematologyThe Egyptian Journal of Haematology, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, stands as a pivotal resource in the field of hematology, particularly within the context of Egypt and the broader Middle Eastern region. This journal is dedicated to disseminating high-quality research that explores the latest advancements in blood disorders, hematologic malignancies, and transfusion medicine. With a focus on original research, case studies, and reviews, it aims to provide a comprehensive platform for hematologists, researchers, and healthcare professionals to enhance their understanding and management of hematological conditions. Although it is not an open-access journal, the rigorous peer-review process ensures that only the most impactful studies are published, contributing to the journal's reputation in the academic community. The Egyptian Journal of Haematology serves as an essential tool for advancing knowledge, improving clinical outcomes, and fostering collaboration among experts in the field.
Cancer Discovery
Pioneering Insights in Cancer Prevention and TreatmentCancer Discovery, published by the American Association for Cancer Research, stands as a vital resource in the oncological research community, renowned for its commitment to disseminating groundbreaking studies and innovative findings in cancer biology, prevention, diagnostics, and treatment. With a significant impact factor reflecting its esteemed position, this journal facilitates open discussions and collaborations, striving to bridge the gap between experimental and clinical research. The journal, which has been active since 2011, is classified as a Q1 publication in 2023, underscoring its influence and authority in the realm of Oncology. By providing a platform for rigorous peer-reviewed articles, Cancer Discovery aims to advance our understanding of cancer and enhance therapeutic strategies, making it an indispensable tool for researchers, professionals, and students eager to stay at the forefront of cancer research.